RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

InDex Pharmaceuticals Holding Debt 2024

InDex Pharmaceuticals Holding Debt

0 SEK

InDex Pharmaceuticals Holding Dividend yield

Ticker

INDEX.ST

ISIN

SE0008966295

WKN

A2ATYC

In 2024, InDex Pharmaceuticals Holding's total debt was 0 SEK, a -100% change from the -341.68 SEK total debt recorded in the previous year.

InDex Pharmaceuticals Holding Aktienanalyse

What does InDex Pharmaceuticals Holding do?

InDex Pharmaceuticals Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding InDex Pharmaceuticals Holding's Debt Structure

InDex Pharmaceuticals Holding's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing InDex Pharmaceuticals Holding's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to InDex Pharmaceuticals Holding’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in InDex Pharmaceuticals Holding’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about InDex Pharmaceuticals Holding Stock

What is the debt of InDex Pharmaceuticals Holding this year?

InDex Pharmaceuticals Holding has a debt level of 0 SEK this year.

What was the debt of InDex Pharmaceuticals Holding compared to the previous year?

The debt of InDex Pharmaceuticals Holding has increased by -100% compared to the previous year dropped.

What are the consequences of high debt for investors in InDex Pharmaceuticals Holding?

High debt can pose a risk for investors of InDex Pharmaceuticals Holding, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of InDex Pharmaceuticals Holding?

Low debt means that InDex Pharmaceuticals Holding has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from InDex Pharmaceuticals Holding affect the company?

An increase in debt of InDex Pharmaceuticals Holding can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of InDex Pharmaceuticals Holding affect the company?

A reduction in debt of InDex Pharmaceuticals Holding can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of InDex Pharmaceuticals Holding?

Some factors that can influence the debt of InDex Pharmaceuticals Holding include investments, acquisitions, operating costs, and revenue development.

Why are the debts of InDex Pharmaceuticals Holding so important for investors?

The debts of InDex Pharmaceuticals Holding are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can InDex Pharmaceuticals Holding take to change the debt?

To change the debt, InDex Pharmaceuticals Holding can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does InDex Pharmaceuticals Holding pay?

Over the past 12 months, InDex Pharmaceuticals Holding paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, InDex Pharmaceuticals Holding is expected to pay a dividend of 0 SEK.

What is the dividend yield of InDex Pharmaceuticals Holding?

The current dividend yield of InDex Pharmaceuticals Holding is .

When does InDex Pharmaceuticals Holding pay dividends?

InDex Pharmaceuticals Holding pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of InDex Pharmaceuticals Holding?

InDex Pharmaceuticals Holding paid dividends every year for the past 0 years.

What is the dividend of InDex Pharmaceuticals Holding?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is InDex Pharmaceuticals Holding located?

InDex Pharmaceuticals Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von InDex Pharmaceuticals Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of InDex Pharmaceuticals Holding from 5/14/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 5/14/2024.

When did InDex Pharmaceuticals Holding pay the last dividend?

The last dividend was paid out on 5/14/2024.

What was the dividend of InDex Pharmaceuticals Holding in the year 2023?

In the year 2023, InDex Pharmaceuticals Holding distributed 0 SEK as dividends.

In which currency does InDex Pharmaceuticals Holding pay out the dividend?

The dividends of InDex Pharmaceuticals Holding are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von InDex Pharmaceuticals Holding

Our stock analysis for InDex Pharmaceuticals Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of InDex Pharmaceuticals Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.